VTAK · Catheter Precision, Inc.
$1.62
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these factors, we have concluded that there is substantial doubt about the Company's ability to continue as a going concern for a period of one year after the date the condensed consolidated financial statements for the quarter ended June 30, 2026 are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$217,318
Shares
1.44M
Volume · Oct 5
11.67M
Avg daily vol (1 sessions)
11.67M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.62
Open$1.60
Day$1.51–1.70
52W close$1.40–30.00
Avg vol 30d592K
Short int23K · 1.6% float · 1.0d
Short vol21%
Last earningsNov 14, 2022
DataMay 2020–Oct 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2026
call held May 16, 2022
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-94.2%
Trailing year
Short interest
1.6%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−84%
below
Price vs 50-day avg
−23%
below
RSI (14)
41
neutral
MACD trend
Positive
52-week position
1%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−23%
trailing
6-month return
−86%
trailing
YTD return
−91%
this year
Relative strength
−97%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $10 — 200d above 50d
Institutional flow
Distributing
-17% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.59% of float · ▼ -42.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
10 holders — mid 3-yr range
Squeeze score
33
low risk · 0–100
Fundamentals
Revenue growth
+3057%
Y/Y
Gross margin
171%
contracting
EPS growth
+90%
Y/Y
Free cash flow
$-8.3M
Balance sheet
$3.0M
net debt
Quant / Vol
risk profile
Volatility
158%
annualized · 1-yr
Max drawdown
−95%
past year
ATR
11.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−84%
Bearish
Price vs 50-day avg
−23%
Bearish
RSI (14)
41
Neutral
MACD trend
Positive
Bullish
52-week position
1%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $10 — 200d above 50d
Institutional flow
Distributing
-17% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.59% of float · ▼ -42.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
10 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $2 · 1%
Range high $30
vs 200-day avg -84%
vs 50-day avg -23%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VTAK
this stock
Catheter Precision, Inc.
|
$217,318 | — | +3057.1% | — | 1.6% |
|
ABT
Abbott Laboratories
|
$174.90B | -20.1% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -8.4% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -18.8% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -55.5% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VTAK | +8.0% | -22.9% | -85.7% | +8.0% | -91.2% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | +6.8% | -23.5% | -97.2% | +6.4% | -104.8% |